Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Adma Biologics (ADMA) Shares Issued: 2011-2025

Historic Shares Issued for Adma Biologics (ADMA) over the last 5 years, with Sep 2025 value amounting to $389,000.

  • Adma Biologics' Shares Issued fell 93.16% to $389,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 57.54%. This contributed to the annual value of $7.5 million for FY2024, which is 578.80% up from last year.
  • According to the latest figures from Q3 2025, Adma Biologics' Shares Issued is $389,000, which was down 81.15% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Shares Issued ranged from a high of $64.6 million in Q4 2022 and a low of $8,000 during Q4 2023.
  • In the last 3 years, Adma Biologics' Shares Issued had a median value of $457,500 in 2023 and averaged $1.1 million.
  • As far as peak fluctuations go, Adma Biologics' Shares Issued tumbled by 99.99% in 2023, and later surged by 5,437.50% in 2024.
  • Adma Biologics' Shares Issued (Quarterly) stood at $53.8 million in 2021, then climbed by 20.09% to $64.6 million in 2022, then crashed by 99.99% to $8,000 in 2023, then soared by 5,437.50% to $443,000 in 2024, then tumbled by 93.16% to $389,000 in 2025.
  • Its last three reported values are $389,000 in Q3 2025, $2.1 million for Q2 2025, and $101,000 during Q1 2025.